Our previous work has also shown that in models of intestinal inflammation, GLP-2 reduces the mucosal content of inflammatory cytokines and TGF-β but increases the macrophage production of IGF-1 [19, 20]. The gene discussed is TGFB1; the disease is inflammatory response.